Where does Mevion Medical Systems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Mevion Medical Systems, Inc. ranks #7,045 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Mevion Medical Systems, Inc. hold?

Mevion Medical Systems, Inc. holds 47 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Mevion Medical Systems, Inc.'s Innovation Score?

Mevion Medical Systems, Inc. has an Innovation Score of 44.6 out of 100 (top 25% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Mevion Medical Systems, Inc.'s patent grant rate increasing or decreasing?

Mevion Medical Systems, Inc.'s recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Mevion Medical Systems, Inc.'s patents?

Mevion Medical Systems, Inc.'s patents average 31.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Mevion Medical Systems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Mevion Medical Systems, Inc.

Q: What technology areas does Mevion Medical Systems, Inc. focus on?

Mevion Medical Systems, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 41 patents. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 47 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Mevion ranks #7,045 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 12 technology areas.

#7,045
of 49,997 US assignees by volume: Top 25%
by Innovation Score (44.6/100): 31.8
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7045 · US Corporation #7,045 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,045/49,997
PHOTO-FINISH Marchesini Group S P A
CPC-FOCUS A61N · 12 areas
INNOV-PAR 44.6/100
CLAIMS-DENSE 31.8 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Marchesini Group S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Defond Electech · near

45
Lincoln Industrial · near

45
Mevion Medical Systems · this assignee

45
MorphoTrust USA · near

45
Phinergy · near

45
3D Lighting… · lowest

7

What this shows Mevion's Innovation Score is 44.6/100 (top 25% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Mevion's grants concentrate

Mevion Medical Systems, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 87.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (8 grants) versus a trough of 2 in 2016. By volume, Mevion sits between Marchesini Group S.P.A. and Nuovo Pignone SPA.

Mevion's three-year grant acceleration

Mevion Medical Systems, Inc. shows 9 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Marchesini Group…

47
Maxar Space

47
Mccormick &

47
Mettler-toledo In…

47
Microchip Technol…

47
Neuboron Medtech

47
Nook Digital

47
Nuovo Pignone SPA

47
Mevion Medical Sy… ◀

47

What this shows Mevion holds 47 patents at rank #7,047, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Mevion

By rank, the assignees closest to #7,047 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Mevion's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mevion, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (45 here).

Lincoln Industrial Corporation 45 Defond Electech Co., Ltd. 45 Phinergy Ltd. 45 MorphoTrust USA, LLC 45

Mevion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 25% higher than 75% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Mevion Medical Systems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	17.0%
2016	2	4.3%
2017	7	14.9%
2018	4	8.5%
2019	6	12.8%
2020	7	14.9%
2021	2	4.3%
2022	3	6.4%
2023	3	6.4%
2024	3	6.4%
2025partial year	2	4.3%

Which technologies does Mevion Medical Systems, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 41

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 31

G21K - Techniques FOR Handling Particles OR Ionising Radiation NOT Otherwise Provided FOR; Irradiation DEVICES; Gamma RAY OR X-ray Microscopes 7

A61B - DIAGNOSIS; SURGERY; Identification 2

H01J - Electric Discharge Tubes OR Discharge Lamps 2

B62B - Hand-propelled Vehicles, e.g. Hand Carts OR PERAMBULATORS; Sledges 1

Y10T - Technical Subjects Covered BY Former US Classification 1

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 1

H02K - Dynamo-electric Machines 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 1

H03L - Automatic Control, Starting, Synchronisation OR Stabilisation OF Generators OF Electronic Oscillations OR Pulses 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#7,045

of 49,997 tracked assignees

Innovation Score

44.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Mevion Medical Systems, Inc.'s patent record in context - here's where to go next.

Mevion Medical Systems, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 87.2% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #7,045 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Mevion Medical Systems, Inc. against Marchesini Group S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.